scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1047995151 |
P356 | DOI | 10.1186/BCR3589 |
P932 | PMC publication ID | 3978715 |
P698 | PubMed publication ID | 24359560 |
P5875 | ResearchGate publication ID | 259446630 |
P50 | author | Rita Schmutzler | Q21264574 |
Alfons Meindl | Q63015490 | ||
Barbara Wappenschmidt | Q63444312 | ||
Kerstin Rhiem | Q92889178 | ||
P2093 | author name string | Eric Hahnen | |
Heide Hellebrand | |||
Jan Hauke | |||
Lutz Garbes | |||
Alexandra Becker | |||
Stefanie Engert | |||
Gioia Schnurbein | |||
Guido Neidhardt | |||
Nana Weber-Lassalle | |||
P2860 | cites work | Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene | Q28280022 |
Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction | Q31109088 | ||
Genetic susceptibility to triple-negative breast cancer | Q36846498 | ||
Germline RAD51C mutations confer susceptibility to ovarian cancer | Q57266552 | ||
RAD51C is a susceptibility gene for ovarian cancer | Q57306209 | ||
Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients | Q85077261 | ||
P433 | issue | 6 | |
P921 | main subject | ovarian cancer | Q172341 |
P304 | page(s) | R120 | |
P577 | publication date | 2013-12-20 | |
P1433 | published in | Breast Cancer Research | Q2208481 |
P1476 | title | RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families | |
P478 | volume | 15 |
Q40495288 | A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer |
Q48097657 | Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers |
Q93164325 | Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer |
Q51764547 | Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. |
Q28253197 | Genetic testing for RAD51C mutations: in the clinic and community |
Q28271817 | Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer |
Q53230114 | Loss of Rad51c accelerates tumourigenesis in sebaceous glands of Trp53-mutant mice. |
Q35657899 | Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech Republic |
Q47141035 | Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations |
Q59538863 | Pathological features of breast and ovarian cancers in RAD51C germline mutation carriers |
Q57083786 | RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families |
Q39434998 | Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH. |
Q33769821 | Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease |
Search more.